WuXi Biologics (Cayman) Inc. (HKG:2269)
36.34
+0.90 (2.54%)
At close: Mar 6, 2026
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 150.36 billion as of March 6, 2026. Its market cap has increased by 75.99% in one year.
Market Cap
150.36B
Enterprise Value
146.72B
Revenue
21.98B
Ranking
n/a
PE Ratio
33.55
Stock Price
36.34
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 150.36B, an increase of 369.30%. That is a compound annual growth rate of 19.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 150.36B | 15.70% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 257.17B |
| Innovent Biologics | 138.90B |
| Sino Biopharmaceutical | 102.08B |
| Akeso | 91.70B |
| Sichuan Kelun-Biotech Biopharmaceutical | 81.15B |
| RemeGen | 51.52B |
| 3SBio | 50.90B |
| Shanghai Henlius Biotech | 34.78B |